Monique Létourneau
Direktor/Vorstandsmitglied bei Oxfam-Québec
Profil
Monique Létourneau is currently the Director at Oxfam-Québec and a Member at Commerce Équitable Oxfam-québec.
Previously, she worked as a Director at Financial Executives International Canada and Génome Québec, Inc. She was also the Chief Financial Officer at Procyon Biopharma, Inc. and Ambrilia Biopharma, Inc. where she held the position of Chief Financial Officer & EVP-Finance from 2001 to 2009.
Ms. Létourneau is a graduate of HEC Montréal.
Aktive Positionen von Monique Létourneau
Unternehmen | Position | Beginn |
---|---|---|
Oxfam-Québec
Oxfam-Québec Miscellaneous Commercial ServicesCommercial Services Part of Stichting Oxfam International, Oxfam-Québec is a non-profit organization based in Montréal, Canada. The Canadian company provides services to end poverty. | Direktor/Vorstandsmitglied | - |
Commerce Équitable Oxfam-québec | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Monique Létourneau
Unternehmen | Position | Ende |
---|---|---|
Financial Executives International Canada
Financial Executives International Canada Miscellaneous Commercial ServicesCommercial Services Financial Executives International Canada operates as a professional membership organization. The company is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 04.06.2014 |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | 19.06.2013 |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Finanzdirektor/CFO | 29.07.2009 |
Procyon Biopharma, Inc.
Procyon Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Procyon Biopharma, Inc. is a biopharmaceutical company engaged in the discovery and development of innovative cancer therapeutic, screening, and diagnostic products and technologies. Procyon has acquired four technologies of which two are broad platform technologies. These two are Prostate Secretory Protein (PSP94), for the prostate cancer market, and the ANA technology platform, that has been developed to improve the immune system and resistibility of cancer. The company is headquartered in Dorval in Québec, Canada | Finanzdirektor/CFO | 03.03.2006 |
Ausbildung von Monique Létourneau
HEC Montréal | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Procyon Biopharma, Inc.
Procyon Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Procyon Biopharma, Inc. is a biopharmaceutical company engaged in the discovery and development of innovative cancer therapeutic, screening, and diagnostic products and technologies. Procyon has acquired four technologies of which two are broad platform technologies. These two are Prostate Secretory Protein (PSP94), for the prostate cancer market, and the ANA technology platform, that has been developed to improve the immune system and resistibility of cancer. The company is headquartered in Dorval in Québec, Canada | Commercial Services |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
Financial Executives International Canada
Financial Executives International Canada Miscellaneous Commercial ServicesCommercial Services Financial Executives International Canada operates as a professional membership organization. The company is headquartered in Toronto, Canada. | Commercial Services |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Oxfam-Québec
Oxfam-Québec Miscellaneous Commercial ServicesCommercial Services Part of Stichting Oxfam International, Oxfam-Québec is a non-profit organization based in Montréal, Canada. The Canadian company provides services to end poverty. | Commercial Services |
Commerce Équitable Oxfam-québec |